{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:37:12Z","timestamp":1777091832552,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ijrobp.2014.07.015","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T14:19:51Z","timestamp":1410272391000},"page":"926-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hypofractionated IMRT of the Prostate Bed After Radical Prostatectomy: Acute Toxicity in the PRIAMOS-1 Trial"],"prefix":"10.1016","volume":"90","clinical-trial-number":[{"clinical-trial-number":"nct01620710","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Sonja","family":"Katayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorbjoern","family":"Striecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Sterzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Habl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Edler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2014.07.015_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1259\/0007-1285-62-740-679","article-title":"The linear-quadratic formula and progress in fractionated radiotherapy","volume":"62","author":"Fowler","year":"1989","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib2","first-page":"1009","article-title":"Is the alpha\/beta ratio for prostate tumours really low and does it vary with the level of risk at diagnosis?","volume":"33","author":"Fowler","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib4","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2013.52.4942","article-title":"Prostate cancer and the hypofractionation hypothesis","volume":"31","author":"Lee","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2010.07.1984","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial","volume":"81","author":"Yeoh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib6","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2009.07.1691","article-title":"A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer","volume":"78","author":"Arcangeli","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.02.049","article-title":"Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer","volume":"84","author":"Arcangeli","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijrobp.2010.07.170","article-title":"Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation","volume":"78","author":"Kuban","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/1471-2407-12-504","article-title":"Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial","volume":"12","author":"Krause","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.juro.2013.05.032","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: AUA\/ASTRO guideline","volume":"190","author":"Thompson","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib13","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","article-title":"Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial","volume":"64","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib16","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ctrv.2013.01.008","article-title":"Systematic review of hypofractionated radiation therapy for prostate cancer","volume":"39","author":"Zaorsky","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.semradonc.2013.01.005","article-title":"Hypofractionation for clinically localized prostate cancer","volume":"23","author":"Cabrera","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib19","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib20","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastasis and improves survival: Long-term followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib21","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib22","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0022-5347(01)66069-5","article-title":"Postoperative radiotherapy for stage pT3 carcinoma of the prostate: Improved local control","volume":"155","author":"Syndikus","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clon.2004.07.006","article-title":"Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy","volume":"16","author":"Lee","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2007.06.042","article-title":"Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy","volume":"70","author":"Wong","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib25","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cncr.25824","article-title":"Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence","volume":"117","author":"Kruser","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib26","first-page":"2785","article-title":"Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial","volume":"33","author":"Massaccesi","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2008.03.021","article-title":"Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study","volume":"88","author":"Cozzarini","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib28","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1016\/j.ijrobp.2012.04.002","article-title":"Conformal postoperative radiotherapy in patients with positive resection margins and\/or pT3-4 prostate adenocarcinoma","volume":"84","author":"Bellavita","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0360-3016(97)00056-4","article-title":"Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy","volume":"39","author":"Zelefsky","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2008.12.059","article-title":"Need for high radiation dose (>or=70 gy) in early postoperative irradiation after radical prostatectomy: A single-institution analysis of 334 high-risk, node-negative patients","volume":"75","author":"Cozzarini","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib31","first-page":"391705","article-title":"Three years of salvage IMRT for prostate cancer: Results of the Montpellier Cancer Center","volume":"2012","author":"Riou","year":"2012","journal-title":"ISRN Urol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2009.08.023","article-title":"Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer","volume":"78","author":"Nath","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2012.05.002","article-title":"Intensity-modulated radiotherapy in the treatment of prostate cancer","volume":"24","author":"Bauman","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib34","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ijrobp.2007.08.003","article-title":"Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer","volume":"70","author":"Kupelian","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2008.07.027","article-title":"Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy","volume":"89","author":"De Meerleer","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2014.07.015_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijrobp.2006.11.024","article-title":"Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy","volume":"67","author":"Neuhof","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614034944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301614034944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T23:28:46Z","timestamp":1538263726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614034944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0360301614034944"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.015","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionated IMRT of the Prostate Bed After Radical Prostatectomy: Acute Toxicity in the PRIAMOS-1 Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}